Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

ConclusionDespite the concerns over unblinding and expectancy, the strength of the effect sizes, fast onset, and enduring therapeutic effects of these psychotherapeutic agents encourage further double-blind, placebo-controlled clinical trials assessing them for management of negative mood and depressive symptoms.

http://link.springer.com/10.1007/s00213-020-05719-1

Source: Psychopharmacology - January 11, 2021 Category: Psychiatry Source Type: research